Articolul precedent |
Articolul urmator |
789 16 |
Ultima descărcare din IBN: 2022-10-19 23:00 |
Căutarea după subiecte similare conform CZU |
547.82 (5) |
Chimie organică (484) |
SM ISO690:2012 LUCENTI, Elena, CARIATI, Elena, FORNI, Alessandra, BOTTA, C., CARLUCCI, L., GIANNIN, C., MARINOTTO, D.. Synthesis and characterization of pyridine-functionalized cyclic triimidazoles. In: Materials Science and Condensed Matter Physics, Ed. 9, 25-28 septembrie 2018, Chișinău. Chișinău, Republica Moldova: Institutul de Fizică Aplicată, 2018, Ediția 9, p. 132. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Materials Science and Condensed Matter Physics Ediția 9, 2018 |
||||||
Conferința "International Conference on Materials Science and Condensed Matter Physics" 9, Chișinău, Moldova, 25-28 septembrie 2018 | ||||||
|
||||||
CZU: 547.82 | ||||||
Pag. 132-132 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The recent discover of the multifaceted emissive features of triimidazo[1,2-a:1',2'-c:1'',2''-e][1,3,5]triazine (cyclic triimidazole) which displays crystallization-induced and mechanochromic emission, together with room temperature ultralong phosphorescence (RTUP) under ambient conditions has highlighted the potentiality of this simple organic molecule [1]. In view of possible applications in Organic Light Emitting Diodes or in fields such as sensing or bioimaging [2], the cyclic scaffold has been functionalized by introduction of the pyridine moiety, a versatile ligand with peculiar properties which opens up also to the fields of pharmaceuticals, catalysis, material science and supramolecular chemistry [3]. Starting from 3-bromotriimidazo[1,2-a:1',2'-c:1'',2''-e][1,3,5]triazine (1), the cyclic triimidazole derivative (2) functionalized with 2-pyridine has been successfully obtained by Stille coupling, while (3), bearing a 4-pyridine substituent, was prepared in high yields by Suzuki–Miyaura reaction. Powder of 2 displays room temperature phosphorescence, for compound 3 phosphorescence was observed only at 77K. The complete spectroscopical characterization together with a structural investigation to elucidate the structure/properties relationships will be here presented. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-71559</cfResPublId> <cfResPublDate>2018</cfResPublDate> <cfVol>Ediția 9</cfVol> <cfStartPage>132</cfStartPage> <cfISBN></cfISBN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/71559</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Synthesis and characterization of pyridine-functionalized cyclic triimidazoles</cfTitle> <cfAbstr cfLangCode='EN' cfTrans='o'><p>The recent discover of the multifaceted emissive features of triimidazo[1,2-a:1',2'-c:1'',2''-e][1,3,5]triazine (cyclic triimidazole) which displays crystallization-induced and mechanochromic emission, together with room temperature ultralong phosphorescence (RTUP) under ambient conditions has highlighted the potentiality of this simple organic molecule [1]. In view of possible applications in Organic Light Emitting Diodes or in fields such as sensing or bioimaging [2], the cyclic scaffold has been functionalized by introduction of the pyridine moiety, a versatile ligand with peculiar properties which opens up also to the fields of pharmaceuticals, catalysis, material science and supramolecular chemistry [3]. Starting from 3-bromotriimidazo[1,2-<em>a</em>:1',2'-<em>c</em>:1'',2''-<em>e</em>][1,3,5]triazine (<strong>1</strong>), the cyclic triimidazole derivative (<strong>2</strong>) functionalized with 2-pyridine has been successfully obtained by Stille coupling, while (<strong>3</strong>), bearing a 4-pyridine substituent, was prepared in high yields by Suzuki–Miyaura reaction. Powder of <strong>2 </strong>displays room temperature phosphorescence, for compound <strong>3 </strong>phosphorescence was observed only at 77K. The complete spectroscopical characterization together with a structural investigation to elucidate the structure/properties relationships will be here presented. </p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-58790</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-54371</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-20904</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-61098</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-61100</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-61101</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-61099</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-58790</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-58790-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Lucenti</cfFamilyNames> <cfFirstNames>Elena</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-54371</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-54371-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Cariati</cfFamilyNames> <cfFirstNames>Elena</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-20904</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-20904-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Forni</cfFamilyNames> <cfFirstNames>Alessandra</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-61098</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-61098-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Botta</cfFamilyNames> <cfFirstNames>C.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-61100</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-61100-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Carlucci</cfFamilyNames> <cfFirstNames>L.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-61101</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-61101-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Giannin</cfFamilyNames> <cfFirstNames>C.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-61099</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-61099-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2018T24:00:00</cfStartDate> <cfFamilyNames>Marinotto</cfFamilyNames> <cfFirstNames>D.</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>